Status:
COMPLETED
Understanding and Reducing HIV Risk Behavior and Substance Use Among Self-identified Bisexual Adolescent Men
Lead Sponsor:
Rosalind Franklin University of Medicine and Science
Conditions:
HIV/AIDS
Substance Use
Eligibility:
All Genders
14-17 years
Phase:
NA
Brief Summary
Young gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. Despite this burden, most HIV prevention interventions target adult MSM (most of whom identify as...
Detailed Description
Young gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. Despite this burden, most HIV prevention interventions target adult MSM (most of whom identify as...
Eligibility Criteria
Inclusion
- Age 14-17
- Identifies as male
- Identifies as bisexual or another non-monosexual identity (e.g., pansexual)
- HIV-negative (self-report)
- Fluent in English
- Lives in United States
Exclusion
- Does not meet inclusion criteria
Key Trial Info
Start Date :
June 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03409328
Start Date
June 11 2021
End Date
January 31 2022
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois, United States, 60064